Viva Raw Issues Voluntary Recall of Two Lots of Dog and Cat Foods Due to Salmonella and Listeria Monocytogenes Contamination
August 25, 2025 – Viva Raw LLC, Charlotte, NC is voluntarily recalling two lots of dog and cat foods due…
FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live). FDA Suspends Biologics License: FDA Safety Communication
On August 22, 2025,the US FDA’s Center for Biologics Evaluation and Research has suspended the biologics license for Valneva Austria…
Follow Instructions for Safe Use of Hyperbaric Oxygen Therapy Devices – Letter to Health Care Providers
The FDA is reminding the public about the safe use of hyperbaric oxygen therapy devices and is providing recommendations to…
Beaver Street Fisheries, LLC Recalls Great Value Frozen Raw Shrimp Because of Possible Health Risk
Beaver Street Fisheries, LLC of Jacksonville, FL is voluntarily recalling a limited quantity of Great Value Frozen Raw Shrimp EZ-Peel…
Blue Bell Ice Cream Issues Allergy Alert on Undeclared Almond, Walnut, and Pecan in Moo-llennium Crunch Ice Cream Packaged in a Chocolate Chip Cookie Dough Half Gallon Carton with a Moo-llennium Crunch Ice Cream Lid
BRENHAM, Texas, August 22, 2025 – Blue Bell Ice Cream is voluntarily recalling a limited quantity of Moo-llennium Crunch Ice…
Vascular Stent Recall: Boston Scientific Removes Carotid WALLSTENT Monorail Endoprosthesis Due to Risk of Resistance During Device Withdrawal
Boston Scientific Removes Carotid WALLSTENT Monorail Endoprosthesis due to risk of resistance during device withdrawal
Southwind Foods, LLC Recalls Frozen Shrimp Because of Possible Health Risk
Southwind Foods, LLC of Carson, California is voluntarily recalling a limited quantity of Frozen Shrimp, due to possible radionuclide (Cesium-137)…
Rationale for FDA’s Position on the Cefazolin Breakpoints for Enterobacterales
Rationale for FDA’s Position on the Cefazolin Breakpoints for Enterobacterales
Rationale for FDA’s Position on the Use of Cefazolin Breakpoints as a Surrogate for Determining Breakpoints for Oral Cephalosporins for the Treatment of Uncomplicated Urinary Tract Infections
Rationale for FDA’s Position on the Use of Cefazolin Breakpoints as a Surrogate for Determining Breakpoints for Oral Cephalosporins for…
FDA Rationale for Breakpoints Recognition Decision: Azithromycin and Neisseria gonorrhoeae
FDA Rationale for Breakpoints Recognition Decision: Azithromycin and Neisseria gonorrhoeae